BiotechTube
Home/NewAmsterdam Pharma Company/Christie Ballantyne, M.D.
CB

Christie Ballantyne, M.D.

Chief of Cardiology (Baylor), Scientific Advisor

NewAmsterdam Pharma Company

Therapeutic Areas

Cardiovascular DiseaseMetabolic DiseaseDyslipidemiaAlzheimer's Disease

NewAmsterdam Pharma Company Pipeline

DrugIndicationPhase
Obicetrapib (TA-8995)Hypercholesterolemia / HeFH / ASCVDPhase 3
Obicetrapib + Ezetimibe FDCHypercholesterolemiaPhase 3

Leadership Team at NewAmsterdam Pharma Company

DM
Dr. Michael Davidson
Co-founding Chief Executive Officer
PD
Professor Dr. John J.P. Kastelein
Co-founder and Chief Scientific Officer
BJ
B.J. Jones
Chief Commercial Officer
EF
Eduardo Fornari
Chief Financial Officer
View full NewAmsterdam Pharma Company profile